University of Chicago’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

University of Chicago’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-325,000	Closed	-$58.5K	–	13
2025 Q1	$58.5K	Sell	325,000 -225,000	-41%	-$116K	0.09%	11
2024 Q4	$360K	Hold	550,000	–	–	0.34%	4
2024 Q3	$208K	Hold	550,000	–	–	0.18%	4
2024 Q2	$699K	Hold	550,000	–	–	0.54%	5
2024 Q1	$1.04M	Hold	550,000	–	–	1.5%	4
2023 Q4	$1.51M	Buy	+550,000	New	+$1.77M	2.1%	5

University of Chicago's NKGN Position: Q2 2025 in Review

University of Chicago sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q2 2025, closing a stake of 325,000 shares — an estimated $58.5K sold.

University of Chicago first reported a position in NKGN in Q4 2023 and held it in 6 quarters. The position peaked at $1.51M in Q4 2023. 0 funds tracked by Wall St. Rank hold NKGN as of Q2 2025.

University of Chicago reported no remaining NKGen Biotech, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
University of Chicago sold 325,000 NKGen Biotech, Inc. Common Stock shares in Q2 2025, an estimated $58.5K.
University of Chicago first reported a position in NKGen Biotech, Inc. Common Stock in Q4 2023 and held it in 6 quarters.
University of Chicago's NKGen Biotech, Inc. Common Stock position peaked at $1.51M in Q4 2023.
0 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q2 2025.

Based on University of Chicago's 13F filing for Q2 2025, filed 7 Aug 2025.